5-151109844-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001155.5(ANXA6):āc.1593A>Cā(p.Glu531Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,599,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001155.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANXA6 | NM_001155.5 | c.1593A>C | p.Glu531Asp | missense_variant, splice_region_variant | 22/26 | ENST00000354546.10 | NP_001146.2 | |
ANXA6 | NM_001363114.2 | c.1575A>C | p.Glu525Asp | missense_variant, splice_region_variant | 21/25 | NP_001350043.1 | ||
ANXA6 | NM_001193544.2 | c.1497A>C | p.Glu499Asp | missense_variant, splice_region_variant | 21/25 | NP_001180473.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000349 AC: 8AN: 229250Hom.: 0 AF XY: 0.0000242 AC XY: 3AN XY: 124020
GnomAD4 exome AF: 0.0000159 AC: 23AN: 1446888Hom.: 0 Cov.: 30 AF XY: 0.0000125 AC XY: 9AN XY: 718888
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2022 | The c.1593A>C (p.E531D) alteration is located in exon 22 (coding exon 21) of the ANXA6 gene. This alteration results from a A to C substitution at nucleotide position 1593, causing the glutamic acid (E) at amino acid position 531 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at